Perinatal complications related to inherited thrombophilia: review of evidence in different regions of the world

References

• Arachchillage DRJ, Makris M. Inherited thrombophilia and pregnancy complications: should we test? Semin Thromb Hemost. 2019;45(1):e1.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL. Thrombophilia. InTech; 2011, 226. Available from: https://www.intechopen.com/books/thrombophilia.
   Google Scholar
• Dobbenga-Rhodes Y. Shedding light on inherited thrombophilias: the impact on pregnancy. J Perinat Neonat Nurs. 2016;30(1):36–44.
   PubMed Web of Science ®Google Scholar
• Duffett L, Rodger M. LMWH to prevent placenta-mediated pregnancy complications: an update. Br J Haematol. 2015;168(5):619–638.
   PubMed Web of Science ®Google Scholar
• Pritchard AM, Hendrix PW, Paidas MJ. Hereditary thrombophilia and recurrent pregnancy loss. Clin Obstet Gynaecol. 2016;59(3):487–497.
   Google Scholar
• Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132(2):171–196.
   PubMed Web of Science ®Google Scholar
• Facco F, You W, Grobman W. Genetic thrombophilias and intrauterine growth restriction: a meta-analysis. Obstet Gynecol. 2009;113(6):1206–1216.
   PubMed Web of Science ®Google Scholar
• Ray JG, Langman LJ, Vermeulen MJ, et al. Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med. 2001;2(3):141–149.
   PubMedGoogle Scholar
• Alsayegh F, Al-Jassar W, Wani S, et al. Venous thromboembolism risk and adequacy of prophylaxis in high-risk pregnancy in the Arabian Gulf. Curr Vasc Pharmacol. 2016;14(4):368–373.
   PubMed Web of Science ®Google Scholar
• Hyde KJ, Schust DJ. Genetic considerations in recurrent pregnancy loss. Cold Spring Harb Perspect Med. 2015;5(3):a023119.
   PubMed Web of Science ®Google Scholar
• WHO recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Acta Obstet Gynecol Scand. 1997;56(3):247–253.
   Google Scholar
• Pandey S, Pandey A, Chauhan UK, et al. Recurrent pregnancy loss and association of MTHFR, PAI-1 and ACE gene polymorphisms in women. IJCBR. 2015;1(4):50–55.
   Google Scholar
• Su MT, Lin SH, Chen YC, et al. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Thromb Haemost. 2013;109(1):8–15.
   PubMed Web of Science ®Google Scholar
• Francis CW. Plasminogen activator inhibitor-1 levels and polymorphisms. Arch Pathol Lab Med. 2002;126(11):1401–1404.
   PubMed Web of Science ®Google Scholar
• Sartori MT, Danesin C, Saggiorato G, et al. The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost. 2003;9(4):299–307.
   PubMed Web of Science ®Google Scholar
• Tsantes AE, Nikolopoulos GK, Bagos PG, et al. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Thromb Haemost. 2007;97(6):907–913.
   PubMed Web of Science ®Google Scholar
• Zinaman MJ, Clegg ED, Brown CC, et al. Estimates of human fertility and pregnancy loss. Fertil Steril. 1996;65(3):503–509.
   PubMed Web of Science ®Google Scholar
• Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010;93(4):1234–1243.
   PubMed Web of Science ®Google Scholar
• Elmahgoub IR, Afify RA, Abdel Aal AA, et al. Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage. J Reprod Immunol. 2014;103:18–22.
   PubMed Web of Science ®Google Scholar
• Parveen F, Tuteja M, Agrawal S. Polymorphisms in MTHFR, MTHFD, and PAI-1 and recurrent miscarriage among North Indian women. Arch Gynecol Obstet. 2013;288(5):1171–1177.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Choi YM, Lee SK, et al. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study. Am J Reprod Immunol. 2014;72(6):571–576.
   PubMed Web of Science ®Google Scholar
• Al Sallout RJ, Sharif FA. Polymorphisms in NOS3, ACE and PAI-1 genes and risk of spontaneous recurrent miscarriage in the Gaza Strip. Med Princ Pract. 2010;19(2):99–104.
   PubMed Web of Science ®Google Scholar
• Mahmutbegovic E, Skonieczna-Zydecka K, Valjevac A, et al. Lack of association between I/D ACE and −675 ID 4G/5G PAI-1 polymorphisms and predicting risk of pregnancy loss (PROPALO) in Bosnian women. In: Badnjevic A, editor. CMBEBIH 2017: Proceedings of the International Conference on Medical and Biological Engineering 2017. Springer Nature Singapore Pte. Ltd.; 2017. p. 440–444.
   Google Scholar
• Ivanov P, Komsa-Penkova R, Konova E, et al. Combined thrombophilic factors among women with late recurrent spontaneous abortions. Akush Ginekol (Sofiia). 2011;50(3):8–12 (in Bulgarian).
   PubMedGoogle Scholar
• Ivanov P, Komsa-Penkova R, Ivanov I, et al. Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss. Akush Ginekol (Sofiia). 2010;49(5):3–8 (in Bulgarian).
   PubMedGoogle Scholar
• Said JM. The impact of inherited thrombophilia on placental haemostasis and adverse pregnancy outcomes. In: Tranquilli A, editor. Thrombophilia. InTech [cited 2014 May 10]. Available from: www.intechopen.com/books/thrombophilia/the-impact-of-inherited-thrombophilia-on-placental-haemostasis-and-adverse-pregnancy-outcomes.
   Google Scholar
• Bozikova A, Gabrikova D, Pitonak J, et al. Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (gypsy) populations. Genet Test Mol Biomarkers. 2015;19(2):98–102.
   PubMed Web of Science ®Google Scholar
• Kasparova D, Vrablik M, Fait T. Is screening for hereditary thrombophilia indicated in first early pregnancy loss? Neuro Endocrinol Lett. 2012;33(1):76–80.
   PubMed Web of Science ®Google Scholar
• Subrt I, Ulcova-Gallova Z, Bibkova K, et al. Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women. Am J Reprod Immunol. 2008;59(3):193–200.
   PubMed Web of Science ®Google Scholar
• Lykke JA, Bare LA, Olsen J, et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J Thromb Haemost. 2012;10(7):1320–1325.
   PubMed Web of Science ®Google Scholar
• Balogh I, Póka R, Losonczy G, et al. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary. Thromb Haemost. 1999;82(5):1555–1556.
   PubMed Web of Science ®Google Scholar
• Rimarova K, Ostro A, Bernasovska K, et al. Reproductive indicators of Roma mothers: cross-sectional study. In: Aghova L, editor. Bratislava: living conditions on health, Public Health Office of the Slovak Republic; 2004. p. 110–114.
   Google Scholar
• Bobak M, Dejmek J, Solansky I, et al. Unfavorable birth outcomes of the Roma women in the Czech Republic and the potential explanations: a population-based study. BMC Public Health. 2005;5(1):106.
   PubMed Web of Science ®Google Scholar
• Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol. 2005;105(1):182–192.
   PubMed Web of Science ®Google Scholar
• Makino A, Nakanishi T, Sugiura-Ogasawara M, et al. No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss. Am J Reprod Immunol. 2004;52(1):60–66.
   PubMed Web of Science ®Google Scholar
• Gasparovic J, Raslová K, Basistová Z, et al. Effect of C677T methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine levels in ethnic groups. Physiol Res. 2004;53(2):215–218.
   PubMed Web of Science ®Google Scholar
• Ang KC, Kathirgamanathan S, Ch’ng ES, et al. Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population. J Assist Reprod Genet. 2017;34(4):517–524.
   PubMed Web of Science ®Google Scholar
• Arshat H, Ann TB, Peng TN. The effects of life cycle and family formation variables on pregnancy outcome. Reprod Health. 1985;3(2):115–125.
   Google Scholar
• Bogdanova N, Horst J, Chlystun M, et al. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet. 2007;16(5):573–578.
   PubMed Web of Science ®Google Scholar
• Nagirnaja L, Nõmmemees D, Rull K, et al. Annexin A5 promoter haplotype M2 is not a risk factor for recurrent pregnancy loss in northern Europe. PLOS One. 2015;10(7):e0131606.
   PubMed Web of Science ®Google Scholar
• Tüttelmann F, Ivanov P, Dietzel C, et al. Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk. Fertil Steril. 2013;100(5):1321–1325.
   PubMed Web of Science ®Google Scholar
• Fenech M. Micronuclei and their association with sperm abnormalities, infertility, pregnancy loss, pre-eclampsia and intra-uterine growth restriction in humans. Mutagenesis. 2011;26(1):63–67.
   PubMed Web of Science ®Google Scholar
• Sosic GM, Jovic N, Rakic B, et al. Association between inherited thrombophilia in pregnancy and micronucleus frequency in peripheral blood lymphocytes. BJMG. 2017;20(2):11–18.
   Web of Science ®Google Scholar
• Turki RF, Assidi M, Banni HA, et al. Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia. BMC Med Genet. 2016;17(1):15–23.
   PubMed Web of Science ®Google Scholar
• Furness DLF, Dekker GA, Hague WM, et al. Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction. Mutagenesis. 2010;25(5):489–498.
   PubMed Web of Science ®Google Scholar
• Toljic M, Egic A, Munjas J, et al. Increased oxidative stress and cytokinesis-block micronucleus cytome assay parameters in pregnant women with gestational diabetes mellitus and gestational arterial hypertension. Reprod Toxicol. 2017;71:55–62.
   PubMed Web of Science ®Google Scholar
• Karsli MF, Baser E, Seckin KD, et al. The impact of inherited thrombophilia on first trimester combined aneuploidy screening test parameters. J Matern Fetal Neonatal Med. 2014;27(4):346–349.
   PubMed Web of Science ®Google Scholar
• Cıkman MS, Seckin KD, Karslı MF, et al. The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers. Arch Gynecol Obstet. 2015;291(4):787–790.
   PubMed Web of Science ®Google Scholar
• Dugalić S, Petronijevic M, Stefanovic A, et al. The association between IUGR and maternal inherited thrombophilias – a case-control study. Med (Baltimore). 2018;97(41):e12799.
   PubMed Web of Science ®Google Scholar